Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Gray matter SWI-filtered phase and atrophy are linked to disability in MS .
Nanoparticle transport across the blood brain barrier.
Pushing Forward: Remyelination as the New Frontier in CNS Diseases.
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.
Dimethyl Fumarate Ameliorates Lewis Rat Experimental Autoimmune Neuritis and Mediates Axonal Protection.
Dimethyl fumarate (BG-12, Tecfidera) approved for use by the NHS in Scotland
Peripheral Bilateral Telangiectasiae in Multiple Sclerosis Patients Treated with Interferon B1a.
Astrocyte-derived lactosylceramide implicated in multiple sclerosis.
IL-17 and GM-CSF Expression Are Antagonistically Regulated by Human T Helper Cells.
Product Portfolio, Meda
Vision Disturbances in Multiple Sclerosis.
Promising Oral Compounds for the Treatment of Multiple Sclerosis: A Glance into the Future.
Advanced Structural and Functional Brain MRI in Multiple Sclerosis.
Mitoxantrone repression of astrocyte activation: Relevance to multiple sclerosis.
Neurovascular coupling in patients with relapsing-remitting multiple sclerosis.
Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease.
Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study.
Copaxone
Improvements in cognition, quality of life, and physical performance with clinical Pilates in multiple sclerosis: a randomized controlled trial.
'Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study.
Biologics-induced autoimmune diseases.
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
Retinyl Palmitate Supplementation Modulates T-bet and Interferon Gamma Gene Expression in Multiple Sclerosis Patients.
Multifocal Tumefactive Demyelination Mimicking Intracranial Neoplasm.
Pages
« first
‹ previous
…
50
51
52
53
54
55
56
57
58
…
next ›
last »